Ambroxol has recently been shown to increase activity of the lysosomal enzyme glucocerebrosidase, so it may be a useful therapeutic agent for both Gaucher disease and Parkinson's disease.
Ambroxol has recently been shown to increase activity of the lysosomal enzyme glucocerebrosidase. It may be a useful therapeutic agent for both Gaucher disease. It may be Parkinson's disease.